$437.23

-1.55%

AMGN

Amgen Inc.

•Healthcare

Biotechnology

Dividend Payer

Overbought

Wide Moat

Biotechnology

Dividend Payer

Overbought

Wide Moat

Loading Chart...

FIT ANALYSIS

Required for personalization

FIT ANALYSIS

Checking Membership...

STOCK DNA

Valuation

4/10

Quality

8/10

Growth

8/10

Strength

2/10

Dividend

6/10

Similar Stocks

BMY Bristol-Myers Squibb Company

REGN Regeneron Pharmaceuticals, Inc.

BIIB Biogen Inc.

EIKN Eikon Therapeutics, Inc.

AZN AstraZeneca PLC

Health Indicators

Price Trend

Upwards

Momentum

Stretched

Balance Sheet

High Leverage

Earnings

Growth

Dividend Yield

2.27%

Market Cap

$236.38B

TALK TO YOUR STOCK

EQUITAI ASSISTANT

Amgen discovers, develops, and manufactures advanced human therapeutics for patients with serious illnesses. The company focuses heavily on complex biologics and targeted medicines in fields like oncology, inflammation, and cardiovascular disease. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.

Talk to Your Stock•open live chat

Pro EquitAI Research

Retrieving premium status...